NCT01414569

Brief Summary

The purpose of this study is to determine if a dose of 40 mg dexamethasone is more effective as pain treatment than the currently used dose of 8 mg after arthroscopic shoulder surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
97

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Nov 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 9, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 11, 2011

Completed
3 months until next milestone

Study Start

First participant enrolled

November 1, 2011

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2013

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2013

Completed
Last Updated

June 4, 2013

Status Verified

June 1, 2013

Enrollment Period

1.4 years

First QC Date

August 9, 2011

Last Update Submit

June 3, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain score by numeric rating scale

    At 8 hours postoperatively

Secondary Outcomes (2)

  • Use of analgesics

    During hospital stay, about 4 hours

  • Pain score by numeric rating scale

    At about 8 a.m. on the first postoperative day

Study Arms (3)

8 mg dexamethasone

ACTIVE COMPARATOR
Drug: Dexamethasone

Placebo, saline

PLACEBO COMPARATOR
Drug: Dexamethasone

40 mg dexamethasone

EXPERIMENTAL
Drug: Dexamethasone

Interventions

Singe dose preoperatively in 100 ml saline intravenously

Also known as: Fortecortin
40 mg dexamethasone8 mg dexamethasonePlacebo, saline

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Arthroscopic subacromial decompression and/or acromioclavicular resection
  • General anaesthesia
  • Daysurgery, Horsens Hospital

You may not qualify if:

  • Incompetent
  • Pregnant
  • Age under 18 or over 90 years
  • Allergy toward dexamethasone
  • Diabetes
  • Active gastric ulcer
  • Untreated hypertension
  • Glaucoma
  • Daily use of glucocorticoids or strong opioids
  • Daily use of analgesics for unrelated illness
  • Myasthenia gravis
  • Mitochondrial disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Horsens Hospital

Horsens, DK-8700, Denmark

Location

Related Publications (1)

  • Bjornholdt KT, Monsted PN, Soballe K, Nikolajsen L. Dexamethasone for pain after outpatient shoulder surgery: a randomised, double-blind, placebo-controlled trial. Acta Anaesthesiol Scand. 2014 Jul;58(6):751-8. doi: 10.1111/aas.12333. Epub 2014 May 13.

MeSH Terms

Conditions

Shoulder Impingement SyndromeArthritis

Interventions

Dexamethasonedexamethasone acetate

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesShoulder InjuriesWounds and Injuries

Intervention Hierarchy (Ancestors)

PregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, Fluorinated

Study Officials

  • Karen T Bjørnholdt, MD

    Aarhus University, Horsens Hospital

    PRINCIPAL INVESTIGATOR
  • Kjeld Søballe, Prof. dr.med.

    Aarhus University Hospital

    STUDY CHAIR
  • Lone Nikolajsen, ph.d., MD

    Aarhus University Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 9, 2011

First Posted

August 11, 2011

Study Start

November 1, 2011

Primary Completion

April 1, 2013

Study Completion

June 1, 2013

Last Updated

June 4, 2013

Record last verified: 2013-06

Locations